Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 1.945M
March 31, 2026 1.841M
December 31, 2025 3.207M
September 30, 2025 1.64M
June 30, 2025 2.028M
March 31, 2025 3.824M
December 31, 2024 -1.414M
September 30, 2024 -25.76M
June 30, 2024 -0.115M
March 31, 2024 0.013M
December 31, 2023 -0.115M
September 30, 2023 -0.972M
June 30, 2023 -2.338M
Date Value
March 31, 2023 -4.312M
December 31, 2022 -4.73M
September 30, 2022 -6.582M
June 30, 2022 -10.92M
March 31, 2022 -5.917M
December 31, 2021 -7.412M
September 30, 2021 -3.907M
June 30, 2021 -4.674M
March 31, 2021 -1.528M
December 31, 2020 -2.658M
September 30, 2020 -0.182M
June 30, 2020 -0.279M
March 31, 2020 1.384M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
MetaStat, Inc. --
Lifecore Biomedical, Inc. -0.513M
Repligen Corp. -2.089M
Bio-Techne Corp. -7.057M
Codexis, Inc. 0.175M